Sang-Young Kim1,2, Wei Chen3, Dost Ongur2, Fei Du1,2. 1. McLean Imaging Center, McLean Hospital, Harvard Medical School, Belmont, Massachusetts, USA. 2. Psychotic Disorders Division, McLean Hospital, Harvard Medical School, Belmont, Massachusetts, USA. 3. Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, Minnesota, USA.
Abstract
PURPOSE: The metabolites phosphocreatine (PCr), adenosine triphosphate (ATP), and in-organic phosphate (Pi) are biochemically coupled. Their pool sizes, assessed by their magnetization ratios, have been extensively studied and reflect bioenergetics status in vivo. However, most such studies have ignored chemical exchange and T1 relaxation effects. In this work, we aimed to extend the T1nom method to simultaneously quantify the reaction rate constants as well as phosphorus metabolite pool size ratios under partially relaxed conditions. MATERIALS AND METHODS: Modified Bloch-McConnell equations were used to simulate the effects of chemical exchanges on T1 relaxation times and magnetization ratios among PCr, γ-ATP, and Pi. The T1nom method with iteration approach was used to measure both reaction constants and metabolite pool size ratios. To validate our method, in vivo data from rat brains (N = 8) at 9.4 Tesla were acquired under two conditions, i.e., approximately full relaxation (TR = 9 s) and partial relaxation (TR = 3 s). We compared metabolite pool size ratios and reaction constants before and after correcting the chemical exchange and T1 relaxation effects. RESULTS: There were significant errors in underestimation of PCr/γATP by 12 % (P = 0.03) and overestimation of ATP/Pi ratios by 14 % (P = 0.04) when not considering chemical exchange effects. These errors were minimized using our iteration approach, resulting in no significant differences (PCr/γATP, P = 0.47; ATP/Pi, P = 0.81) in metabolite pool size ratios and reaction constants between the two measurements (i.e., short versus long TR conditions). CONCLUSION: Our method can facilitate broad biomedical applications of 31 P magnetization saturation transfer spectroscopy, requiring high temporal and/or spatial resolution for assessment of altered bioenergetics. LEVEL OF EVIDENCE: 2 Technical Efficacy: Stage 1 J. Magn. Reson. Imaging 2018;47:210-221.
PURPOSE: The metabolites phosphocreatine (PCr), adenosine triphosphate (ATP), and in-organic phosphate (Pi) are biochemically coupled. Their pool sizes, assessed by their magnetization ratios, have been extensively studied and reflect bioenergetics status in vivo. However, most such studies have ignored chemical exchange and T1 relaxation effects. In this work, we aimed to extend the T1nom method to simultaneously quantify the reaction rate constants as well as phosphorus metabolite pool size ratios under partially relaxed conditions. MATERIALS AND METHODS: Modified Bloch-McConnell equations were used to simulate the effects of chemical exchanges on T1 relaxation times and magnetization ratios among PCr, γ-ATP, and Pi. The T1nom method with iteration approach was used to measure both reaction constants and metabolite pool size ratios. To validate our method, in vivo data from rat brains (N = 8) at 9.4 Tesla were acquired under two conditions, i.e., approximately full relaxation (TR = 9 s) and partial relaxation (TR = 3 s). We compared metabolite pool size ratios and reaction constants before and after correcting the chemical exchange and T1 relaxation effects. RESULTS: There were significant errors in underestimation of PCr/γATP by 12 % (P = 0.03) and overestimation of ATP/Pi ratios by 14 % (P = 0.04) when not considering chemical exchange effects. These errors were minimized using our iteration approach, resulting in no significant differences (PCr/γATP, P = 0.47; ATP/Pi, P = 0.81) in metabolite pool size ratios and reaction constants between the two measurements (i.e., short versus long TR conditions). CONCLUSION: Our method can facilitate broad biomedical applications of 31 P magnetization saturation transfer spectroscopy, requiring high temporal and/or spatial resolution for assessment of altered bioenergetics. LEVEL OF EVIDENCE: 2 Technical Efficacy: Stage 1 J. Magn. Reson. Imaging 2018;47:210-221.
Authors: David G Harper; J Eric Jensen; Caitlin Ravichandran; Roy H Perlis; Maurizio Fava; Perry F Renshaw; Dan V Iosifescu Journal: Neuropsychopharmacology Date: 2016-09-02 Impact factor: 7.853
Authors: Valeria Righi; Caterina Constantinou; Dionyssios Mintzopoulos; Nadeem Khan; S P Mupparaju; Laurence G Rahme; Harold M Swartz; Hazel H Szeto; Ronald G Tompkins; A Aria Tzika Journal: FASEB J Date: 2013-03-12 Impact factor: 5.191
Authors: Fei Du; Alissa J Cooper; Thida Thida; Selma Sehovic; Scott E Lukas; Bruce M Cohen; Xiaoliang Zhang; Dost Ongür Journal: JAMA Psychiatry Date: 2014-01 Impact factor: 21.596
Authors: Kristian Rink; Moritz C Berger; Andreas Korzowski; Mathies Breithaupt; Armin Biller; Peter Bachert; Armin M Nagel Journal: Magn Reson Imaging Date: 2015-08-04 Impact factor: 2.546
Authors: Alexander C Phillips; Alison Sleigh; Catherine J McAllister; Soren Brage; T Adrian Carpenter; Graham J Kemp; Anthony J Holland Journal: PLoS One Date: 2013-12-31 Impact factor: 3.240
Authors: Bart L van de Bank; Marnix C Maas; Lauren J Bains; Arend Heerschap; Tom W J Scheenen Journal: Brain Struct Funct Date: 2018-03-23 Impact factor: 3.270